Marc Dunoyer
CEO, Rare Diseases
Analyst — Rare Disease Business Leader
CEO
Analyst — Rare Diseases
Analyst — Chief of Rare Diseases
Earnings-call appearances
-
Astrazeneca PLC Q1 FY2026 Earnings Call2026-03-31
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q4 FY2025 Earnings Call2025-12-31
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q3 FY2025 Earnings Call2025-09-30
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q2 FY2025 Earnings Call2025-06-30
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q1 FY2025 Earnings Call2025-03-31
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q4 FY2024 Earnings Call2024-12-31
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q3 FY2024 Earnings Call2024-09-30
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q2 FY2024 Earnings Call2024-06-30
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q1 FY2024 Earnings Call2024-03-31
Astrazeneca PLC (AZN)
-
Astrazeneca PLC Q4 FY2023 Earnings Call2023-12-31
Astrazeneca PLC (AZN)